Showing results (71-80 of 436) with videos related to

Sort By:
Pageof 44
Inflammatory Bowel Diseases|April 4, 2026
Efficacy and safety of ulcerative colitis therapies do not differ by age: A post hoc analysis of randomized controlled trialsEmily C L Wong, John K Marshall, Christopher Ma, et al.
Annals of the Rheumatic Diseases|September 26, 2025
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)Dafne Capelusnik, Clementina Lopez-Medina, Désirée van der Heijde, et al.
Journal of Clinical Pharmacology|January 31, 2018
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard SystemAlexander Eser, Christian Primas, Sieglinde Reinisch, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysisParul Tandon, Navneet Natt, Gurpreet Malhi, et al.
The American Journal of Gastroenterology|December 23, 2008
Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnosticsWolfgang Tillinger, Ruth Jilch, Bernd Jilma, et al.
AJR. American Journal of Roentgenology|November 24, 2005
Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's diseaseJohannes Sailer, Philipp Peloschek, Ewald Schober, et al.
Inflammatory Bowel Diseases|April 28, 2023
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity IndexEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|June 16, 2025
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Wiener Klinische Wochenschrift|December 1, 2022
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early RespondersEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Pageof 44